Skip to main content
. Author manuscript; available in PMC: 2015 Jun 22.
Published in final edited form as: Arthritis Care Res (Hoboken). 2013 May;65(5):745–752. doi: 10.1002/acr.21889

Table 1.

Patient demographics and sJIA disease characteristic

Study Cohort
n=25 (%)
CARRA Registry
Cohort
n=389 (%)**
P
Value
Age at sJIA diagnosis
Mean ± SD (range)
7.4 ± 5.5 (1.1 – 17.2) 5.8 ± 4.3 (0.2 – 15.9) NS*
Disease duration (Months) 51.6 ± 48.8 (8–173)# 61.9 ± 51 (0.6–219.5) 0.012
Female 19 (76) 213 (55) 0.040
Race NS
  Caucasian 17 (68) 302 (78)
  Black 7 (28) 45 (12)
  Asian 1 (4) 20 (5)
  Other/Unknown 0 (0) 20 (5)
Ethnicity NS
  Hispanic 5 (20) 50 (13)
  Non-Hispanic 20 (80) 337 (87)
JIA Symptoms (ever during disease course)
  Fever 25 (100) 352 (93) NS
  Rash 23 (92) 326 (87) NS
  Arthritis 25 (100) 378 (100) NS
  Lymphadenopathy 19 (76) 157 (46) <0.001
  Hepato/Splenomegaly 20 (80) 102 (31) <0.001
  Serositis 14 (56) Unknown NA
Decade of disease onset 0.0068
  1980s 1 (4) 0
  1990s 5 (20) 35 (9)
  2000 and later 19 (76) 335 (87)
  Unknown 0 16 (4)
*

NS: not significant means P>0.05

**

The sum of all frequencies may not be equal to total sample size due to missing values.

#

At the time of pulmonary diagnosis

NA: Not applicable